"We look forward to … creating more dialogue about the latest in cancer care through OncLive's Strategic Alliance Partnership," said Robert S. DiPaola, M.D., director of Rutgers Cancer Institute of New Jersey.
PLAINSBORO, N.J. (PRWEB) February 10, 2015
OncLive® today welcomes Rutgers Cancer Institute of New Jersey as a partner in promoting awareness of the most recent advances in cancer care through OncLive’s Strategic Alliance Partnership program.
In the new partnership, OncLive’s editorial and marketing teams will publicize important news from Rutgers Cancer Institute of New Jersey, where distinguished researchers and clinicians work together to improve the prevention, detection, treatment and care of patients with cancer. Rutgers Cancer Institute of New Jersey is designated by the National Cancer Institute as the state’s only Comprehensive Cancer Center for its scientific excellence and capacity to combine multiple research approaches to tackle cancer comprehensively.
Mike J. Hennessy Jr., senior vice president, oncology & specialty pharmacy, which includes OncLive, said, “We are honored to partner with Rutgers Cancer Institute of New Jersey to spread the word about new developments in cancer research and care. Whenever there is an organization like the Cancer Institute of New Jersey making discoveries and providing the latest medicines and most advanced treatment options to patients, real potential exists to inspire other institutions by sharing the stories behind those accomplishments.”
Robert S. DiPaola, M.D., director of Rutgers Cancer Institute of New Jersey, said, “We are committed to providing patients with a compassionate team of experts and the most advanced cancer care available, including access to clinical trials available only at NCI-designated Cancer Centers like ours. We collaborate broadly across our state and the country and we look forward to enhancing that reach by creating more dialogue about the latest in cancer care through OncLive’s Strategic Alliance Partnership program.”
Rutgers Cancer Institute of New Jersey joins more than 30 other leading cancer centers, nursing schools and physician groups around the country in partnering with OncLive.
Hennessy added, “This partnership and the broader Strategic Alliance benefits everyone dedicated to the fight against cancer. Collaborating, sharing information and working together increases our chances of finding the most powerful ways to combat this disease.”
OncLive.com is the official website for Intellisphere’s Oncology Specialty Group, which publishes Oncology & Biotech News, OncologyLive, Oncology Nursing News, and Contemporary Oncology. OncLive offers oncology professionals resources and information to provide the best care for their patients. Intellisphere, LLC, a leading provider of healthcare publishing, research, and education, is part of the Michael J. Hennessy Associates, Inc. (MJH) family of businesses, based in Plainsboro, N.J. MJH also includes the acclaimed CURE Media Group, which combines science and humanity to make cancer understandable. Its flagship product is CURE™ magazine, the largest consumer publication in the U.S. focused entirely on cancer, reaching cancer patients, cancer centers, and advocacy groups. To learn more, please visit http://www.OncLive.com.
About Rutgers Cancer Institute of New Jersey
Rutgers Cancer Institute of New Jersey (http://www.cinj.org) is the state’s first and only National Cancer Institute-designated Comprehensive Cancer Center. As part of Rutgers, The State University of New Jersey, the Cancer Institute of New Jersey is dedicated to improving the detection, treatment and care of patients with cancer and to serving as an education resource for cancer prevention. Physician-scientists at the Cancer Institute engage in translational research, transforming their laboratory discoveries into clinical practice, quite literally bringing research to life. Follow the Institute on Facebook at http://www.facebook.com/TheCINJ.
For Cancer Institute of New Jersey: Michele Fisher, 732-235-9872, michele.fisher(at)rutgers(dot)edu
For OncLive: Becky Taylor, 609-240-6886, becky(at)btaylorpa(dot)com